Recovery After an Initial Schizophrenia Episode
Psychiatrist, John Kane, M.D. and Clincial Psychologist, Susan Azrin join us at the annual National Council for Behavioral Health conference to discuss their presentation on recovery after initial schizophrenia episodes. The program RAISE is funded by the National Institute of Mental Health. It was designed to reduce the likelihood of long-term disability that people with schizophrenia often experience.
Susan T. Azrin, PhD Program Chief, Primary Care Research Program Division of Services and Intervention Research National Institute of Mental Health Representing: Researchers Susan T. Azrin, PhD, is Program Chief of the Primary Care Research Program within the Division of Services and Intervention Research at the National Institute of Mental Health (NIMH). In this capacity she manages a large portfolio of grants supporting research on the detection, diagnosis, management, and treatment of mental disorders in non-specialty settings that include general medicine, pediatrics, emergency rooms, home and nurse visitation, Ob/Gyn practice and aging services. Dr. Azrin serves as a Project Officer for the NIMH Recovery After Initial Schizophrenia Episode (RAISE), a large-scale study testing the effectiveness of a coordinated multi-component treatment for first-episode schizophrenia in preventing disability and improving functioning, and Scientific Officer for the Mental Health Research Network. She also leads an NIMH initiative on improving health and reducing premature mortality in people with severe mental illnesses. Prior to coming to NIMH, Dr. Azrin served as a Senior Study Director at Westat where she directed a wide array of research projects on mental health services. Dr. Azrin earned her doctorate in clinical psychology at the University of Maryland College Park.
John M. Kane, MD is Vice President for Behavioral Health Services of the North Shore – Long Island Jewish Health System and Chairman of Psychiatry at The Zucker Hillside Hospital. He is Professor of Psychiatry, Neurology and Neuroscience and holds the Dr. E. Richard Feinberg Chair in Schizophrenia Research at the Albert Einstein College of Medicine. Dr. Kane received his B.A. from Cornell University and his M.D. from the New York University School of Medicine. He currently directs the NIMH-funded Advanced Center for Interventions and Services Research in Schizophrenia at The Zucker Hillside Hospital. He has been a member of the Board of Scientific Counselors for NIMH, and he has served on the council of the American College of Neuropsychopharmacology. He has chaired the NIMH Psychopathology and Psychobiology Review Committee as well as the Psychopharmacologic Drugs Advisory Committee of the Food and Drug Administration.
Dr. Kane is a recipient of the Arthur P. Noyes Award in Schizophrenia, the NAPPH Presidential Award for Research, the American Psychiatric Association Foundations’ Fund Prize for Research, the Kempf Fund Award for Research Development in Psychobiological Psychiatry, the Lieber Prize for Outstanding Research in Schizophrenia, the Heinz E. Lehmann Research Award from New York State, and the Dean Award from the American College of Psychiatrists.